JP2013514329A5 - - Google Patents

Download PDF

Info

Publication number
JP2013514329A5
JP2013514329A5 JP2012543778A JP2012543778A JP2013514329A5 JP 2013514329 A5 JP2013514329 A5 JP 2013514329A5 JP 2012543778 A JP2012543778 A JP 2012543778A JP 2012543778 A JP2012543778 A JP 2012543778A JP 2013514329 A5 JP2013514329 A5 JP 2013514329A5
Authority
JP
Japan
Prior art keywords
linker
compound
compound according
alkyl
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012543778A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013514329A (ja
JP5879268B2 (ja
Filing date
Publication date
Priority claimed from NO20093555A external-priority patent/NO331773B1/no
Application filed filed Critical
Publication of JP2013514329A publication Critical patent/JP2013514329A/ja
Publication of JP2013514329A5 publication Critical patent/JP2013514329A5/ja
Application granted granted Critical
Publication of JP5879268B2 publication Critical patent/JP5879268B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012543778A 2009-12-18 2010-12-17 マンガンキレート並びに磁気共鳴イメージング(mri)における造影剤としての使用 Active JP5879268B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20093555A NO331773B1 (no) 2009-12-18 2009-12-18 Mangankelater, sammensetninger omfattende slike og anvendelse av disse som kontrastmidler for magnettomografi (MR)
NO20093555 2009-12-18
PCT/EP2010/070029 WO2011073371A1 (en) 2009-12-18 2010-12-17 Manganese chelates and their use as contrast agents in magnetic resonance imaging (mri)

Publications (3)

Publication Number Publication Date
JP2013514329A JP2013514329A (ja) 2013-04-25
JP2013514329A5 true JP2013514329A5 (enExample) 2014-02-06
JP5879268B2 JP5879268B2 (ja) 2016-03-08

Family

ID=43770529

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012543778A Active JP5879268B2 (ja) 2009-12-18 2010-12-17 マンガンキレート並びに磁気共鳴イメージング(mri)における造影剤としての使用

Country Status (19)

Country Link
US (1) US9486544B2 (enExample)
EP (1) EP2512524B1 (enExample)
JP (1) JP5879268B2 (enExample)
KR (1) KR101860160B1 (enExample)
CN (1) CN102639152B (enExample)
AU (1) AU2010332760B2 (enExample)
BR (1) BR112012013761A2 (enExample)
CA (1) CA2781228A1 (enExample)
DK (1) DK2512524T3 (enExample)
ES (1) ES2606165T3 (enExample)
HR (1) HRP20161627T1 (enExample)
HU (1) HUE032152T2 (enExample)
LT (1) LT2512524T (enExample)
MX (1) MX2012007041A (enExample)
NO (1) NO331773B1 (enExample)
PL (1) PL2512524T3 (enExample)
PT (1) PT2512524T (enExample)
RU (1) RU2561718C2 (enExample)
WO (1) WO2011073371A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2988756T4 (da) 2013-04-26 2022-08-08 Guerbet Sa Formulering af kontraststof og dertil knyttet fremstillingsfremgangsmåde
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
EP3380484A1 (en) 2015-11-26 2018-10-03 Debreceni Egyetem New 6-oxa-3,9, 15-triaza-bicyclo[9.3.1 ]pentadec a- 1 ( 14), 1 1 ( 15), 12-triene derivatives based compounds and their application as ligands of essential metal ion based mri and 52mn based pet contrast agents
WO2017089847A1 (en) 2015-11-26 2017-06-01 Debreceni Egyetem New 3,6,9, 15-tetraaza-bicyclo [9.3.1 ]pentadeca- 1(14), 11(15), 12-triene based compounds and their application as ligands of essential metal ion based mri and 52mn based pet contrast agents
US10968224B2 (en) 2015-11-26 2021-04-06 Debreceni Egyetem 2,11-diaza-[3.3](2,6)pyridinophane compounds and their application as ligands of essential metal ion based MRI contrast agents and 52MN based PET contrast agents
GB201610738D0 (en) * 2016-06-20 2016-08-03 Ge Healthcare As Chelate compounds
WO2018096082A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
PL3558394T3 (pl) * 2016-12-21 2020-11-16 Ge Healthcare As Oparte na tetraazabicyklo-makrocyklu związki chelatowe manganu odpowiednie jako środki do obrazowania metodą MRI
EP3728168B1 (en) * 2017-12-20 2022-03-30 General Electric Company Anionic chelate compounds
MY208484A (en) 2018-11-23 2025-05-13 Bayer Pharma AG Formulation of contrast media and process of preparation thereof
CN111233982B (zh) * 2018-11-28 2023-03-03 深圳先进技术研究院 一种小分子蛋白质及其应用
HUE069750T2 (hu) 2019-09-03 2025-04-28 Ge Healthcare As Mangán-kelát izomerek
CN114874214B (zh) * 2022-05-31 2023-03-21 南京航空航天大学 可偶联巯基的双功能大环螯合剂衍生物及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU608759B2 (en) 1986-08-04 1991-04-18 Amersham Health Salutar Inc NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
US5334371A (en) * 1988-07-20 1994-08-02 Schering Aktiengesellschaft Marcocyclic polyaza bicyclo compounds containing 5 or 6 membered rings, and method for MRI
DE68908185T2 (de) 1988-09-27 1993-11-25 Nycomed Salutar Inc Chelat-zusammensetzung.
ES2145041T3 (es) * 1991-12-10 2000-07-01 Dow Chemical Co Complejos de acidos biciclopoliazamacrociclocarboxilicos, sus conjugados, preparacion y uso como agentes de contraste.
ZA929576B (en) * 1991-12-10 1994-06-10 Dow Chemical Co Bicyclopolyazamacrocyclophosphonic acids their complexes and conjugates for use as contrast agents and processes for their preparation
US5428139A (en) * 1991-12-10 1995-06-27 The Dow Chemical Company Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals
FI933506A7 (fi) * 1993-05-06 1994-11-07 Dow Global Technologies Inc Bisyklopolyatsamakrosyklokarboksyylihappokomplekseja, niiden konjugaat teja, menetelmä niiden valmistamiseksi ja käyttö varjoaineina
FR2836916B1 (fr) * 2002-03-05 2004-06-11 Guerbet Sa Oligomeres de chelates de gadolinium, leur application comme produits de contraste en imagerie par resonance magnetique et leurs intermediaires de synthese
FR2856689A1 (fr) * 2003-06-25 2004-12-31 Guerbet Sa Composes specifiques a forte relaxivite
US20080305049A1 (en) 2005-01-31 2008-12-11 Hadassa Degani Mri Contrast Agents for Diagnosis and Prognosis of Tumors

Similar Documents

Publication Publication Date Title
JP2013514329A5 (enExample)
RU2012124266A (ru) Хелаты марганца и их применение в качестве контрастных агентов в магнитно-резонансной визуализации (mpb)
JP2016153410A5 (enExample)
JP2010521485A5 (enExample)
JP2012255007A5 (enExample)
JP2013507423A5 (enExample)
JP2014501307A5 (enExample)
JP2015512946A5 (enExample)
JP2013534248A5 (enExample)
RU2015149527A (ru) Производные доластатина 10 и ауристатинов
JP2011057686A5 (enExample)
JP2014515013A5 (enExample)
HRP20161577T1 (hr) Inhibitori replikacije virusa gripe
JP2019500327A5 (enExample)
JP2011528654A5 (enExample)
RU2014141545A (ru) Нацеливающие аминокислотные липиды
JP2013523896A5 (enExample)
WO2009095226A3 (en) NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS
JP2012515219A5 (enExample)
JP2014527974A5 (enExample)
JP2012521201A5 (enExample)
JP2012506896A5 (enExample)
JP2013523975A5 (enExample)
AR080491A1 (es) Formulaciones orales y sales lipofilicas de metilnaltrexona
RU2016130448A (ru) Пептидные дендримеры, содержащие фибриноген-связывающие пептиды